This is a episode from podcasts.apple.com.
To find out more about the podcast go to Why an early Alzheimer’s theory is making a comeback, the U.S.’s electricity crisis, and improving precision medicine.
To find out more about the podcast go to Why an early Alzheimer’s theory is making a comeback, the U.S.’s electricity crisis, and improving precision medicine.
Below is a short summary and detailed review of this podcast written by FutureFactual:
Alzheimer's cholinergic comeback, US electricity grid crisis, and pharmacogenomics with All of Us data
Overview
The podcast presents three science-driven stories: a revival of the cholinergic hypothesis in Alzheimer's disease, a deep dive into the electricity transmission crisis in the United States, and a pharmacogenomics study leveraging the All of Us dataset to guide medicine prescribing.
Key insights
- Cholinergic system resurgence in Alzheimer's involves acetylcholine signaling, basal forebrain hub neurons, imaging advances, and tau related pathology alongside the amyloid story.
- US grid challenges are framed as governance and policy issues rather than purely technical barriers, with proposals for federal and state reform and new build models.
- Pharmacogenomics using All of Us data reveals that most patients carry actionable variants and that large, diverse datasets can inform prescribing guidelines and clinical decision support.

